preclinical observations on eribulin for breast cancer
Published 7 years ago • 361 plays • Length 5:48Download video MP4
Download video MP3
Similar videos
-
9:49
patient selection for eribulin in breast cancer
-
6:51
treatment with eribulin mesylate in metastatic breast cancer
-
5:25
eribulin in metastatic breast cancer
-
3:40
treatment with eribulin in metastatic breast cancer
-
2:20
dr. llombart-cussac on eribulin in her2-negative metastatic breast cancer
-
2:08
dr. joyce o'shaughnessy on eribulin in metastatic breast cancer
-
6:09
dual moa for eribulin in breast cancer
-
1:22
dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
-
1:00
dr. mcintyre on eribulin as first-line therapy in her2- breast cancer
-
2:42
eribulin as treatment for metastatic breast cancer
-
1:58
dr. alvarez on updated findings with eribulin in patients with her2 breast cancer
-
1:18
dr. christopher twelves on eribulin mesylate in combination therapies for breast cancer
-
1:58
dr. twelves on a pooled analysis of eribulin in breast cancer
-
1:32
dr. gary schwartz on the survival benefit of eribulin in sarcoma
-
0:59
dr. linda vahdat on frontline eribulin plus trastuzumab in her2-positive mbc
-
11:28
recent data on eribulin in metastatic breast cancer patients from sabcs
-
7:11
chemotherapeutics in metastatic breast cancer
-
4:12
eribulin in recurrent metastatic er breast cancer
-
1:06
dr. tolaney on pembrolizumab plus eribulin in tnbc